Cleared Traditional

K932165 - INTRAVASCULAR ADMINISTRATION SET

K932165 is an FDA 510(k) clearance for INTRAVASCULAR ADMINISTRATION SET, manufactured by Mcgaw, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 344-day FDA review.

K932165 · Mcgaw, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1994
Decision
344d
Days
Class 2
Risk

K932165 is an FDA 510(k) clearance for the INTRAVASCULAR ADMINISTRATION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Mcgaw, Inc. (Irvine, US). The FDA issued a Cleared decision on April 13, 1994 after a review of 344 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Mcgaw, Inc. devices

FDA 510(k) Submission Details - K932165

510(k) Number K932165 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 1993
Decision Date April 13, 1994
Days to Decision 344 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
215d slower than avg
Panel avg: 129d · This submission: 344d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 681
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K932165.
CONTROL-A-FLO(TM) REGULATOR
K940867 · Baxter Healthcare Corp · May 1994
PRIMARY ADMIN SET W/UNIV SP-MAN BELOW/ABV PUMP CH
K931173 · Imed Corp. · Apr 1994
MEASURED VOLUME SOLUTION ADMINISTRATION SET
K940054 · Puritas Health Care, Inc. · Apr 1994
WINGED INFUSION SET A-PORT VASCULAR ACCESS SYSTEM
K940056 · Puritas Health Care, Inc. · Apr 1994
LIFECARE PLUMSET VENTED SECONDARY I.V. SET
K933326 · Abbott Laboratories · Mar 1994
INFUSION ADMINISTRATION SET
K940053 · Puritas Health Care, Inc. · Mar 1994